全部

1·Hepatorenal syndrome (HRS) is a well-recognized complication of end-stage liver disease.

肝肾综合征是一项肝病晚期普遍的并发症。

2·Objective: to study the effectiveness of ascites back transfusion treating hepatorenal syndrome.

前言：目的：研究用腹水回输方法综合治疗肝肾综合征的疗效。

3·During hospitalization, refractory ascites occurred in 1 case and hepatorenal syndrome in another.

住院期间发生顽固性腹水、肝肾综合征各1例。

4·Objective to investigate the predictive factors and the best prognostic parameter of hepatorenal syndrome (HRS).

目的探讨影响肝肾综合征(HRS)预后的参数及最佳预后指标。

5·The clinical data of 12 cases with hepatorenal syndrome(HRS)admitted from October 1984 to May 1989 in our hospital are analyzed.

本文分析了12例肝肾综合征病人的临床特点和治疗。

6·Nowadays the combination of Terlipressin and albumin infusion is, I wouldn't say standard, but the preferred treatment for hepatorenal syndrome.

现在特利加压素联合白蛋白输注治疗是肝肾综合症的标准或者是有效的治疗。

7·Methods: The data of treatment of hepatorenal syndrome by ascites back transfusion combined with vasoactive substance was retrospectively analyzed.

方法：回顾分析我院近年来以腹水直接回输，合并应用血管活性药物治疗肝肾综合征的资料。

8·Methods 13 severe hepatitis patients with hepatorenal syndrome were treated with plasma exchange and hemofiltration compared to 13 with conventional medicine therapy.

方法应用血浆置换加持续血液滤过治疗13例重型肝炎合并肝肾综合征患者并与单纯药物治疗进行比较。

9·He added that waiting times for donor livers are getting ever longer, and it is now known that hepatorenal syndrome does not always improve after a liver transplant, so guidelines are needed.

他指出，等候捐肝者的期间相当长，而在肝脏移植后肝肾症候群症状不一定会有所改善，所以才需要规范。

10·The plasma levels of atrial natriuretic peptide (ANP) were determined by radioimmunoassay in 13 healthy volunteers and 19 patients with cirrhotic ascites and 17 with hepatorenal syndrome (HRS).

作者应用放射免疫法测定了正常人13例、肝硬变腹水19例和肝肾综合征17例(HRS)患者血浆心钠素(anp)的含量。